West Pharmaceutical Services (WST)

Operating Cash Flow (Statement)

$662.20M

TTM · Period ending: · USD

WST logo

WST Operating Cash Flow (Statement)

Latest reported$662.20M
WST TTM Cash from Operations ($36.00M → $662.20M)
High-resolution chart · PNG

WST operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

West Pharmaceutical Services Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
39,800,000
38,300,000
48,600,000
62,500,000
63,200,000
66,500,000
69,400,000
71,200,000
85,000,000
76,000,000
71,000,000
53,900,000
49,100,000
65,100,000
67,700,000
73,300,000
75,700,000
63,400,000
63,400,000
59,800,000
52,900,000
50,100,000
46,100,000
50,100,000
48,400,000
49,800,000
49,800,000
49,000,000
40,600,000
42,700,000
38,500,000
34,400,000
39,300,000
39,900,000
34,000,000
36,200,000
37,200,000
35,000,000
44,400,000
37,800,000
35,400,000
32,500,000
36,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.